Project Grant R37CA291990
Award Date 8/1/24
Completion Date 2/28/25
Dollars Obligated $2.2M
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
North Carolina, USA
Similar Awards
- Federal Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded The Regents of the University of Colorado-Denver a Project Grant totaling $2.89 million under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct a comprehensive, multidisciplinary investigation of cannabis use's impact on pain and recovery following total knee arthroplasty (TKA) surgery. The research, which commenced September 5, 2025, and extends through August 31, 2030,...
- Federal Project Grant Award Summary The National Cancer Institute awarded The Institute For Cancer Research a $429,162 Project Grant (CFDA 93.395, Cancer Treatment Research program) effective August 1, 2025 through July 31, 2027 to conduct a prospective feasibility study exploring the neuroprotective potential of cannabidiol (CBD) in preventing oxaliplatin-induced peripheral neuropathy in colorectal cancer patients. The research deliverables include: (1) evaluation of the feasibility and...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded The University of Kentucky Research Foundation a $647,142 Project Grant on February 15, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct controlled research examining the impact of cannabis on opioid self-administration in individuals with opioid use disorder. The research will be completed by November 30, 2030, and will deliver fundamental public health data addressing a critical gap...
- Federal Grant Award Summary Washington State University received a $153,000 Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) beginning June 15, 2025, and concluding May 31, 2027. The award supports a six-month longitudinal research study examining the relationship between naturalistic cannabis use and daily functioning in young adults with chronic pain using an innovative ecological momentary assessment burst...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded Albert Einstein College of Medicine a $199,584 Project Grant, effective March 15, 2026, through February 28, 2031, under the Drug Use and Addiction Research Programs (CFDA 93.279). Dr. Michele Buonora will conduct a five-year hybrid effectiveness-implementation study examining patient-controlled analgesia (PCA) for acute pain management in hospitalized individuals with opioid use disorder (POUD). The research will...
- Federal Grant Award Summary The Medical University of South Carolina received a $686,692 Project Grant from the National Institute on Drug Abuse under the Drug Use and Addiction Research Programs (CFDA 93.279) beginning September 1, 2025, and concluding July 31, 2030. This award supports a prospective clinical trial investigating the potential benefits of cannabis use reduction as a harm reduction strategy for adults with cannabis use disorder (CUD). The research addresses a significant gap in...
- This $668,110 Project Grant awarded by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) will fund the development and acceptability testing of a technology-based intervention to reduce cannabis misuse among college students. The project aims to refine an existing intervention that provides information on cannabis products, marketing, laws, and risks to increase young adults' cannabis literacy. The research will involve focus groups with...
- Federal Grant Award Summary Oregon Health & Science University received a $791,990 Project Grant award effective June 15, 2025, from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct a longitudinal mechanistic study examining reciprocal relationships between cannabis use, sleep, and hypothalamic-pituitary-adrenal (HPA) axis functioning. The three-year research initiative (completion date April 30, 2030) will enroll 60...
- Grant Award Summary Media REZ LLC (doing business as Daniel Greenberg & Associates) received a $404,295 Project Grant from the National Cancer Institute under the Cancer Cause and Prevention Research program (CFDA 93.393) awarded on September 8, 2025, with a completion date of August 31, 2026. The award funds the development of a patient-directed Virtual Reality (VR) intervention designed to provide non-pharmacologic management of chronic cancer pain. The project employs an iterative,...
- Federal Grant Award Summary Medstar Health Research Institute Inc. received a $403,383 Project Grant award from the National Cancer Institute under the Cancer Treatment Research program (CFDA 93.395) on June 1, 2025, with completion anticipated by May 31, 2027. The award supports the development and feasibility testing of a cognitive behavioral theory-assisted virtual reality (VR) therapeutic device prototype designed to address chronic cancer pain management. The project, conducted in...